Berkeley Catalyst Fund (BCF)
32
17M
22
3.56
5
0.31
2
- Stages of investment
- Areas of investment
Summary
Berkeley Catalyst Fund (BCF) is the famous VC, which was founded in 2015. The company was established in North America in United States. The main department of described VC is located in the San Francisco.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Nanotechnology, Genetics. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline 4D Molecular Therapeutics, Nelumbo
The important activity for fund was in 2018. The fund is constantly included in 2-6 investment rounds annually. Speaking about the real fund results, this VC is 47 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Berkeley Catalyst Fund (BCF), startups are often financed by SOSV, IndieBio, Cystic Fibrosis Foundation. The meaningful sponsors for the fund in investment in the same round are Viking Global Investors, University of Michigan MINTS fund, UPC Renewables. In the next rounds fund is usually obtained by SOSV, IndieBio.
Besides them, we counted 2 critical employees of this fund in our database.
Investments analytics
Analytics
- Total investments
- 32
- Lead investments
- 5
- Exits
- 2
- Rounds per year
- 3.56
- Follow on index
- 0.31
- Investments by industry
- Biotechnology (17)
- Health Care (12)
- Medical (9)
- Therapeutics (6)
- Medical Device (6) Show 23 more
- Investments by region
-
- United States (31)
- Ireland (1)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 590K
- Group Appearance index
- 0.88
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Akadeum Life Sciences | 12 Oct 2021 | Biotechnology, Information Technology, Medical | Early Stage Venture | 17M | United States, Ann Arbor, Michigan |
| KnoWEwell | 16 Sep 2020 | Health Care, Wellness, Communities, Marketplace | Early Stage Venture | 925K | |
| Oyla AI | 01 Jan 2021 | Machine Learning, 3D Technology | Seed | United States, California, San Carlos | |
| ShopKeep | 17 Jan 2012 | Software, Retail, SaaS, Enterprise Software, Cloud Computing, Point of Sale | Early Stage Venture | 2M | United States, New York |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.